Back to Search
Start Over
Action Sites and Clinical Application of HIF-1α Inhibitors
- Source :
- Molecules, Vol 27, Iss 11, p 3426 (2022)
- Publication Year :
- 2022
- Publisher :
- MDPI AG, 2022.
-
Abstract
- Hypoxia-inducible factor-1α (HIF-1α) is widely distributed in human cells, and it can form different signaling pathways with various upstream and downstream proteins, mediate hypoxia signals, regulate cells to produce a series of compensatory responses to hypoxia, and play an important role in the physiological and pathological processes of the body, so it is a focus of biomedical research. In recent years, various types of HIF-1α inhibitors have been designed and synthesized and are expected to become a new class of drugs for the treatment of diseases such as tumors, leukemia, diabetes, and ischemic diseases. This article mainly reviews the structure and functional regulation of HIF-1α, the modes of action of HIF-1α inhibitors, and the application of HIF-1α inhibitors during the treatment of diseases.
- Subjects :
- HIF-1α
HIF-1α inhibitor
tumor
leukemia
disease treatment
Organic chemistry
QD241-441
Subjects
Details
- Language :
- English
- ISSN :
- 27113426 and 14203049
- Volume :
- 27
- Issue :
- 11
- Database :
- Directory of Open Access Journals
- Journal :
- Molecules
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.fac7ece2f6ae42c28b3bf9809ff69727
- Document Type :
- article
- Full Text :
- https://doi.org/10.3390/molecules27113426